Inicio › Cáncer de seno › Connecticut

Ensayos clínicos de Cáncer de seno en Connecticut

50 estudios sobre Cáncer de seno buscan participantes en Connecticut.

Ciudades en Connecticut

Texto oficial del estudio (inglés)

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Yale University - Yale University School of Medicine, New Haven

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07360314

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Yale Cancer Center, New Haven

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07222267

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

Eastern CT Hematology and Oncology Associates, Norwich

ReclutandoFase 3

Edades de 18 en adelante · Mujeres · Actualizado el 12 nov 2026 · NCT07541079

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Smilow Cancer Hospital - Yale New Haven Health, New Haven
Yale-New Haven Hospital-Yale Cancer Center, New Haven
Smilow Cancer Hospital Phase 1 Unit, New Haven
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT04557449

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Yale Cancer Center, New Haven

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Yale University School of Medicine, New Haven

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06324357

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Hartford Healthcare Institute, Hartford
Yale Cancer Center, New Haven

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Yale Cancer Center, New Haven

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Yale-New Haven Hospital-Yale Cancer Center, New Haven

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

UConn Health, Farmington

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07174336

E-Mindfulness Approaches for Living After Breast Cancer

Stamford Hospital/Bennett Cancer Center, Stamford

ReclutandoFase 3

Edades de 18 a 50 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Hartford HealthCare - Avon, Avon
Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
Danbury Hospital, Danbury
y 19 más

ReclutandoFase 3

Edades de 18 a 60 · Mujeres · Actualizado el 4 nov 2026 · NCT05879926

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

Yale University School Of Medicine, New Haven

ReclutandoFase 1

Edades de 18 en adelante · Mujeres · Actualizado el 3 nov 2026 · NCT07524855

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Yale Cancer Center, New Haven

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07578571

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Smilow Cancer Hospital Care Center - Derby, Derby
Smilow Cancer Hospital Care Center - Fairfield, Fairfield
Smilow Cancer Hospital at Glastonbury, Glastonbury
y 10 más

ReclutandoFase 3

Edades de 60 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06377852

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Yale Cancer Center, New Haven

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478

The Cancer of the Pancreas Screening-5 CAPS5)Study

Yale University, New Haven

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT02000089

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Smilow Cancer Hospital - Derby, Derby
Smilow Cancer Hospital - Fairfield, Fairfield
Smilow Cancer Hospital - Glastonbury, Glastonbury
y 11 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07062965

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Stamford Hospital ( Site 0049), Stamford

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06312176

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Yale University, Yale Cancer Center, New Haven

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06993844

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Yale University, New Haven

ReclutandoFase 2

Edades de 40 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06749210

A Study of PHST001 in Advanced Solid Tumors

Yale Cancer Center, New Haven

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Yale Cancer Center, New Haven

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

Yale University School of Medicine - Yale Cancer Center, New Haven

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT07701941

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, New Haven

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05867251

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, New Haven

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06103864

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, New Have

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07229313

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, New Haven

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07085767

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Norwalk Hospital, Norwalk

ReclutandoFase 2

Edades de 45 en adelante · Mujeres · Actualizado el 21 sept 2026 · NCT04084730

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Yale Cancer Center Clinical Trials Office, New Haven

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07340541

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Smilow Cancer Hospital at Yale New Haven, New Haven

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06072612

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Yale University Cancer Center, New Haven

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT06533826

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Yale Cancer Center, New Haven

Reclutando

Edades de 18 a 44 · Mujeres · Actualizado el 19 ago 2026 · NCT06275126

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Smilow Cancer Hospital Care center at Derby, Derby
Smilow Cancer Hospital Care center at Fairfield, Fairfield
Smilow Cancer Hospital Care center at Glastonbury, Glastonbury
y 11 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT04893109

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Yale Cancer Center - Smilow Cancer Hospital, New Haven

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 6 ago 2026 · NCT05232916

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Norwalk Hospital, Norwalk

ReclutandoFase 2

Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Yale University, New Haven

ReclutandoFase 3

Edades de 65 en adelante · Mujeres · Actualizado el 30 jun 2026 · NCT06507618

Integrated Cancer Repository for Cancer Research

Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns

Yale Cancer Center, New Haven

ReclutandoEstudio observacional

Edades de 18 a 80 · Mujeres · Actualizado el 22 may 2026 · NCT06551220

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.